Wound Healing Summit (July 2012, Chicago, IL USA)
The Angiogenesis Foundation and the American College of Wound Healing and Tissue Repair jointly convened a high-level multi-stakeholder Expert Summit in Chicago, IL, in July 2012 to assess recent developments in wound care and to address the outcomes and experiences valued by patients suffering from chronic and delayed healing wounds—a condition that affects millions of Americans and costs the U.S. healthcare system an estimated $20 billion annually.
The Expert Summit led to a first-of-its-kind white paper that summarizes the issues, identified the desired state of the wound care field from a patient perspective, and presents a framework for defining and assessing patient-centered outcomes in chronic wound treatment.
The resulting white paper that was created is available for download by clicking below:
The Angiogenesis Foundation convened two advocacy summits for critical limb ischemia (CLI) in 2010. CLI is a condition characterized by chronic ischemic at-rest pain, ulcers, or gangrene in one or both legs attributable to peripheral arterial disease (PAD), and is an area of substantial unmet medical need and active research. To address this global issue, the Angiogenesis Foundation brought together a multidisciplinary group of leading CLI experts from North America and Europe at two conferences held in Crystal City, Virginia (June 2010) and Berlin, Germany (October 2010), respectively.
CLI and ischemic amputation is an example of major cardiovascular health disparity, with high differentiation in patient outcomes. This is not due to genetics, but rather to the lack of a “system of care” that would provide consistent high quality. The care pathways through which PAD patients navigate, from their initial diagnosis to progression to CLI to amputation and beyond, are extremely complex.
The experts, who represented the wide range of medical and pharmacological disciplines that deal with CLI, undertook a situation analysis in their respective continents, then broke into working groups to address four major issues for the complex ideas: the obstacles and challenges for improving outcomes in CLI, generating disease awareness, establishing care pathways, and value analysis & reimbursement. From the working groups, volunteers agreed to take concrete action steps to further their work after the conference.
The Angiogenesis Foundation organized and convened the European CLI Summit in October 2010 to highlight and discuss the unmet needs and emerging therapeutic solutions for critical limb ischaemia (CLI) in the international community. As a third party with international convening power across diverse stakeholder groups, the Foundation invited leaders from medical associations, medical centers, regulatory, payer, health policy, advocacy groups, and industry. Highly interactive and professionally moderated with graphical facilitation, the summit successfully identified the major issues, opportunities, challenges, and solutions for advancing the medical treatment and improved outcomes of patients with CLI.
The Angiogenesis Foundation convened an expert panel on October 27-28, 2008 to discuss the issues and challenges facing new technology, therapy development, and reimbursement in the fields of tissue repair and regenerative medicine. To learn more about R4, please contact us.